U.S. FDA approves kos drug advisor
Kos Pharmaceuticals Inc. said it won final approval from the U.S. Food and Drug Administration to market Advisor, a cholesterol-lowering drug that could become an important weapon in the battle
Kos Pharmaceuticals Inc. said it won final approval from the U.S. Food and Drug Administration to market Advisor, a cholesterol-lowering drug that could become an important weapon in the battle